drugmaker

Drugmaker seeks approval for China’s first biosimilar Ozempic
Drugmaker seeks approval for China’s first biosimilar Ozempic
A DRUGMAKER in China has developed a biosimilar version of Novo Nordisk’s popular diabetes drug Ozempic and applied for approval to sell it there, in a potential challenge to...
Japan drugmaker reports two more deaths in supplement scare
Japan drugmaker reports two more deaths in supplement scare
 A JAPANESE drugmaker whose dietary supplements are at the centre of a growing health scare reported on Thursday two more deaths potentially related to its tablets.Last week, Kobayashi Pharmaceutical...